Economic Impact of AstraZeneca
AstraZeneca is one of the world’s major pharmaceutical companies, developing new medicines that make a meaningful difference to patients’ lives. It has a very strong base within the UK and is a major contributor to its economy, science and innovation investment, and to patient health.
Regeneris Consulting assessed the economic contribution of the company to the UK and its regions on behalf of Astra Zeneca. This included the benefits which arise from its substantial investment in R&D and workforce development, as well as its wider social and community contribution.
Our assessment informed AstraZeneca’s communication with a range of stakeholders, its inputs into the decisions of government and regulators linked to the pharmaceutical sector, as well as its own Corporate and Social Responsibility statements.
A detailed analysis of AstraZeneca's economic contribution to the UK and its regions